10x Genomics, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| 10x Genomics, Inc. | TXG - NASDAQ |
$31.00-$35.00 | $39.00 | $54.00 | 9 million | 9/12/2019 |
| JP Morgan, Goldman Sachs, BofA Merrill Lynch | ||||||
Co-Manager(s): Cowen | ||||||
| Health Care | ||||||
Filing(s): Filed 2019-08-19 Terms Added 2019-09-03 Terms Changed 2019-09-10 | ||||||
10x Genomics, Inc. Quote & Chart - Click for current quote - TXG
IPO Boutique aggregates information on public companies and private companies, such as "TXG" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About 10x Genomics, Inc. (adapted from 10x Genomics, Inc. prospectus):
They are a life science technology company building products to interrogate, understand and master biology.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a life science technology company building products to interrogate, understand and master biology.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "TXG" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.